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The most common pancreatic cancer is adenocarcinoma. Primary adenosquamous cell carcinoma of the pancreas is 
very rare and aggressive. A 46-year-old man presented with a 3-month history of dyspepsia and a 7-kg weight loss. The 
physical examination showed tenderness of the right upper quadrant of the abdomen. There was no jaundice. Amylase 
and lipase were elevated. CA 19-9 was elevated to 566.7 U/mL. Gastroduodenoscopy showed a hard ulceroinfiltrative 
mass with a yellowish exudate that bled readily on touch in the second portion of the duodenum. Abdominal computed 
tomography showed a 7.1 × 6.3-cm heterogeneously enhancing mass in the pancreatic head. The pancreatic mass had 
invaded the duodenum wall, gastric antrum, and gastroduodenal artery sheath. Fine-needle aspiration biopsy of the 
pancreatic mass revealed adenosquamous cell carcinoma, anaplastic type. We concluded that an adenosquamous cell 
carcinoma of pancreas had invaded the duodenal mucosa causing ulceration.
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INTRODUCTION
Pancreatic cancer is the second most common gastro-
intestinal malignancy in the United States [1] and the fifth 
most common malignancy in Korea [2]. More than 95% of 
malignant neoplasms of the pancreas arise from exocrine 
glands. Ductal adenocarcinoma accounts for 80-85% of 
pancreatic tumors [3,4]. By contrast, adenosquamous cell 
carcinoma of the pancreas is very rare and aggressive [4] 
and accounts for 1-4% of all exocrine malignancies of the 
pancreas based on autopsy and surgical specimens [5]. 
A rare case of pancreatic adenosquamous cell carcinoma 
with duodenal invasion is reported, and the literature is 
reviewed.
CASE REPORT
A 46-year-old man presented with a 3-month history 
of dyspepsia and a 7-kg weight loss. He had no history 
of any disease. He did not smoke and drank alcoholic 
beverages in moderation. On admission, the patient’s 
vital signs were stable. His family history was negative 
for malignancy. Direct tenderness was noted over 
the right upper quadrant area of the abdomen, but 
rebound tenderness and Murphy’s sign were absent. 
The remainder of the examination was unremarkable. 
The complete blood count showed a white cell count of 
7,800/mm
3 (70.9% neutrophils), hemoglobin 10.3 g/dL, 
hematocrit 29.2%, and platelet count of 283,000/mm
3. 
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The blood chemistry showed a fasting glucose level of 
107 mg/dL, urea nitrogen 19 mg/dL, creatinine 0.8 mg/
dL, total protein 6.1 g/dL, albumin 4.0 g/dL, aspartate 
transaminase 13 IU/L, alanine aminotransferase 12 IU/
L, alkaline phosphatase 238 IU/L, total bilirubin 0.6 mg/
dL, total cholesterol 170 mg/dL, and triglyceride 64 mg/
dL. The serum amylase was elevated slightly to 170 U/L, 
and the serum lipase to 338 U/L. The carcinoembryonic 
antigen (CEA) was 3.3 ng/mL, α-fetoprotein was 1.5 
ng/mL, and the CA 19-9 was elevated to 566.7 ng/mL. 
Gastroduodenoscopy showed a hard ulceroinfiltrative 
mass with a yellowish exudate that bled readily on touch 
at the second portion of the duodenum (Fig. 1A). Initially, 
we thought that he had duodenal cancer. However, a 
biopsy of the duodenum showed adenosquamous cell 
carcinoma (Fig. 1B). Abdominal computed tomography 
showed a 7.1 × 6.3-cm heterogeneously enhancing mass in 
the pancreatic head. The main pancreatic duct was dilated 
due to compression by the mass. The tumor mass invaded 
the duodenum, gastric antrum, and gastroduodenal artery 
sheath. Multiple enlarged lymph nodes were seen around 
the left gastric vessel, greater omentum, and small bowel 
mesentery (Fig. 2A). Fine-needle aspiration biopsy of the 
pancreatic mass revealed adenosquamous cell carcinoma, 
anaplastic type (Fig. 2B). We diagnosed primary adeno-
squamous cell carcinoma of the pancreas that had invaded 
A
Figure 1. (A) Gastroduodenoscopy showed hard ulceroinfiltrative mass with yellowish exudates and easy touch bleeding at second 
portion of duodenum. (B) The tumor cells showed mostly squamous differentiation with focal adenocarcinoma, showing cytoplasmic 
mucins (arrows) (H&E, × 200).
B
A
Figure 2. (A) In abdominal pelvis CT, it showed 7.1 × 6.3 cm-sized heterogeneous enhancing mass in pancreatic head portion. Multiple 
lymph node enlargements were seen around left gastric vessel, greater omentum, and small bowel mesentery (arrows). (B) Fine needle 
aspiration biopsy of the pancreatic mass revealed mostly squamous differentiation with focal adenocarcinoma with anaplastic type (H&E, 
× 200). 
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the duodenum, resulting in an ulceroinfiltrative lesion. 
The patient refused palliative management and was 
discharged.
DISCUSSION
Pancreatic cancer includes ductal adenosquamous 
carcinoma, endocrine neoplasms, cystic tumors, 
solid pseudopapillary tumors, acinar cell carcinoma, 
adenocarcinoma, squamous cell carcinoma, primary 
lymphoma of the pancreas, and metastatic lesions to the 
pancreas [6]. Pancreatic cancer originates mainly from the 
exocrine duct cells, with more than 80% showing exocrine 
adenomatous morphology [4]. Pancreatic adenosquamous 
cell carcinoma is very rare. Based on autopsy studies and 
surgical specimens, it accounts for 1-4% of all exocrine 
malignancies of the pancreas [5]. A review of data taken 
from various cancer registries on 6,668 cases of exocrine 
pancreatic cancer treated between 1950 and 1985 revealed 
36 cases (0.005%) of squamous carcinoma and 68 cases 
(0.01%) of adenosquamous carcinoma [7].
Male and old age (over 60) are predominant [5,8]. Com-
mon symptoms are abdominal pain, weight loss, and 
painless jaundice [8,9]. The mass most commonly involves 
the pancreatic head [8,9]. There are no specific radiologic 
findings that distinguish this tumor from common 
ductal cell adenocarcinoma of the pancreas [5]. Nabae 
et al. [10] stated that the presence of central necrosis in 
a huge infiltrative pancreatic tumor was suggestive of 
adenosquamous carcinoma of the pancreas.
The histogenesis of adenosquamous cell carcinoma of 
the pancreas remains uncertain, and several different 
hypotheses have been offered: 1) a preexisting adeno-
carcinoma undergoing squamous cell transformation; 2) 
heterotopic squamous epithelium undergoing a malignant 
change; and 3) a stem cell capable of differentiating into ei-
ther a squamous or glandular cell undergoing a malignant 
change [5,11,12]. Morohoshi et al. [4] proposed a similar 
hypothesis.
A pathological diagnosis can be made using percutane-
ous needle aspiration or at surgery. Rahemtullah et al. [8] 
reported that the cytological features derived from a fine-
needle aspiration biopsy are diagnostic of adenosquamous 
cell carcinoma of the pancreas. A few patients undergo 
surgery because most of them are reported to have stage 
IV disease at the time of presentation [8]. Our patient’s 
diagnosis was adenosquamous cell carcinoma of the 
pancreas based on a percutaneous needle aspiration 
biopsy.
Major surgery does not have a substantial benefit for 
patients with adenosquamous cell carcinoma of the 
pancreas, especially those with severe comorbidities [13]. 
The prognosis of patients with adenosquamous carcinoma 
of the pancreas is less favorable than that of patients with 
common ductal cell carcinoma of the pancreas. Smit et 
al. [13] reported that the survival averaged 5.7 months 
for 72 patients with adenosquamous carcinoma of the 
pancreas, and only five patients survived for more than 1 
year. Kardon et al. [9] reported that the overall survival 
was 12.5 months for patients treated with resection and 
adjuvant chemotherapy and 3.0 months for the patients 
who received no or palliative chemotherapy. Most patients 
had a poor prognosis despite aggressive surgery with 
or without adjuvant therapy [13]. In Korea, seven cases 
(including our case) have been reported (one case of 
squamous cell carcinoma, six cases of adenosquamous 
cell carcinoma) [14-19]. These cases showed a male 
predominance (M:F = 5:2) and a mean patient age of 61.7 
± 11.1 years. The common symptoms were abdominal pain 
in seven (100%) and weight loss in four (57.1%). No case 
had jaundice. Lipase was elevated in three (42.9%), CA19-
9 in two (28.6%), and CEA in one (14.3%). On CT, the 
masses were located in the pancreas head in three (42.9%), 
body in one (14.3%), and tail in three (42.9%). Central 
necrosis was observed in three (42.9%), and metastasis in 
six (85.7%). The median survival was 3.3 months, and the 
mean survival was 3.6 ± 1.9 months. The prognosis in all 
cases was very poor, although one case was treated with 
adjuvant chemotherapy. Table 1 summarizes the clinical 
findings for the Korean cases.
In Korea, adenosquamous cell carcinoma of pancreas is 
very rare and aggressive. It has a poor prognosis and short 
survival with any treatment. Our case had a pancreatic 
mass with duodenal invasion. Multiple enlarged lymph 
nodes were seen around the left gastric vessel, greater 
omentum, and small bowel mesentery. We recommended 
adjuvant treatment, but the patient refused.
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Table 1. Summary of the cases reported in Korea
Reference Sex/Age Symptoms
Location
(size, cm)
Type of mass Metastasis Pathology Treatment
Survival,
mon
Our case M/46 ABD pain, weight loss, 
nausea, vomiting
Head (7 × 6) Heterogeneously   
  enhancing mass
Multiple ASC Supportive
Ban et al. [14] M/70 ABD pain Head (6 × 7) Submucosal solid mass Duodenum SCC Surgery 1.7
Chung et al. [15] F/47 ABD pain, weight loss Tail (10 × 9) Homogenous enhancing  
  mass
Multiple ASC Surgery
Song et al. [16] M/60 ABD pain Body (14 × 12) Huge cystic mass with CN Stomach ASC Surgery 4.0
Lee et al. [17] F/62 ABD pain, weight loss Tail (8 × 7) Cystic mass with CN Multiple ASC Surgery + 
chemotherapy
2.7
Shin et al. [18] M/64 ABD pain Head (3 × 4) Cystic mass None ASC Surgery
Kim et al. [19] M/76 ABD pain Tail (9 × 8) Cystic and solid mass  
  with CN
Multiple ASC Surgery 6.0
ABD, abdominal; ASC, adenosquamous cell carcinoma; SCC, squamous cell carcinoma; CN, central necrosis.